BU BÖLÜM HAKKINDA
BUFFALO, NY – September 17, 2026 – A new #commentary was #published in Volume 17 of Oncotarget on September 11, 2026, titled “Are both COVID-19 and COVID-19 vaccines associated with cancer?”
The paper was authored by Raphael Lataster, an independent researcher at the University of Sydney, and responds to a recent Oncotarget review by Charlotte Kuperwasser and Wafik S. El-Deiry examining published reports concerning cancer following COVID-19 vaccination or infection.
Lataster highlights research concerning potential associations between COVID-19 and cancer and discusses mechanisms proposed in the literature. He argues that similar mechanisms reported in connection with COVID-19 vaccination warrant consideration and further study.
The commentary also highlights differences in how evidence concerning COVID-19 vaccines and cancer has been evaluated in the scientific literature. He calls for the same evidentiary standards to be applied when considering potential links between COVID-19 infection, vaccination, and cancer.
“Such inquiries should proceed without preconceptions, applying the same evidentiary standards regardless of whether findings implicate infection, vaccination, or both.”
The commentary does not establish a causal relationship between COVID-19 vaccination and cancer. Rather, it calls for potential associations and biological mechanisms to be investigated without predetermined conclusions and with appropriate consideration of alternative explanations and the limitations of observational evidence.
DOI - https://doi.org/10.18632/oncotarget.28918
Correspondence to - Raphael Lataster - okaythennews@gmail.com (ORCID: https://orcid.org/0000-0002-6670-1702)
Preview video - https://www.youtube.com/watch?v=uSbIKNe3Hho
Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28918
Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/
Keywords - cancer, COVID-19, COVID-19 vaccines, double standards
To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us:
Facebook - https://www.facebook.com/Oncotarget/
X - https://twitter.com/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/@OncotargetJournal
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh
MEDIA@IMPACTJOURNALS.COM
The paper was authored by Raphael Lataster, an independent researcher at the University of Sydney, and responds to a recent Oncotarget review by Charlotte Kuperwasser and Wafik S. El-Deiry examining published reports concerning cancer following COVID-19 vaccination or infection.
Lataster highlights research concerning potential associations between COVID-19 and cancer and discusses mechanisms proposed in the literature. He argues that similar mechanisms reported in connection with COVID-19 vaccination warrant consideration and further study.
The commentary also highlights differences in how evidence concerning COVID-19 vaccines and cancer has been evaluated in the scientific literature. He calls for the same evidentiary standards to be applied when considering potential links between COVID-19 infection, vaccination, and cancer.
“Such inquiries should proceed without preconceptions, applying the same evidentiary standards regardless of whether findings implicate infection, vaccination, or both.”
The commentary does not establish a causal relationship between COVID-19 vaccination and cancer. Rather, it calls for potential associations and biological mechanisms to be investigated without predetermined conclusions and with appropriate consideration of alternative explanations and the limitations of observational evidence.
DOI - https://doi.org/10.18632/oncotarget.28918
Correspondence to - Raphael Lataster - okaythennews@gmail.com (ORCID: https://orcid.org/0000-0002-6670-1702)
Preview video - https://www.youtube.com/watch?v=uSbIKNe3Hho
Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28918
Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/
Keywords - cancer, COVID-19, COVID-19 vaccines, double standards
To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us:
Facebook - https://www.facebook.com/Oncotarget/
X - https://twitter.com/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/@OncotargetJournal
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh
MEDIA@IMPACTJOURNALS.COM
ingilizce
Amerika Birleşik Devletleri
TRANSKRİPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
BU PODCAST'IN DİĞER BÖLÜMLERİ
BUFFALO, NY – August 31, 2026 – A new #editorial was published in Volume 17 of Oncotarget on June 8, 2026, titled “Tumor infiltrating lymphocyte (TIL) therapy for treating the solid tumors: Challenges and future perspectives.”
The editorial was led by first and corresponding author Bhartendra Shar…
BUFFALO, NY – August 25, 2026 – A new precision oncology paper was #published in Volume 17 of Oncotarget on August 14, 2026, titled “Systematic methodological flaws in DNA contamination assessment of mRNA vaccines: A critical analysis of Achs et al. (2025).”
The article was led by first and corres…
BUFFALO, NY – August 28, 2026 – A new #research paper was published in Volume 17 of Oncotarget on August 19, 2026, titled “Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine.”
The study was led by first author Kelly Crane from the Department of Ur…
BUFFALO, NY – September 1, 2026 – A new #review was published in Volume 17 of Oncotarget on August 28, 2026, titled “Emerging biomedical imaging applications of tumor-derived extracellular vesicles for premetastatic niche detection: Biological rationale, engineering strategies, and translational ch…
Head and neck squamous cell carcinoma (HNSCC) can return even after patients complete surgery, radiation, chemotherapy, or combinations of these treatments. Preventing recurrence therefore remains an important challenge in head and neck cancer care. Human papillomavirus (HPV), particularly HPV type…
Feragatname: Bu sayfaya yerleştirilmiş podcast ve sanat eserleri, sahibinin mülkiyetinde olan ve Listen Notes, Inc.'e bağlı olmayan veya tarafından onaylanmayan Oncotarget Podcast'e aittir.
DÜZENLE
Podcast veritabanını güncel tutmaya yardımcı olduğunuz için teşekkür ederiz.
